Vifor (International) Inc.

10 clinical trials · Sponsor

Record	Firm	Date
Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients (NCT05625542)	Vifor (International) Inc.	2023-06-10
Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients (NCT05524467)	Vifor (International) Inc.	2023-02-02
RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients (NCT05460234)	Vifor (International) Inc.	2022-10-05
Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease (NCT04817670)	Vifor (International) Inc.	2021-11-18
Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects (NCT05077436)	Vifor (International) Inc.	2021-10-14
Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia (NCT04938635)	Vifor (International) Inc.	2021-09-20
Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia (NCT04864795)	Vifor (International) Inc.	2021-04-19
Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia (NCT04364269)	Vifor (International) Inc.	2020-06-11

Every clearance here is in the API, with alerts when new ones post.